ADME-AP: a database of ADME associated proteins

被引:19
作者
Sun, LZ [1 ]
Ji, ZL [1 ]
Chen, X [1 ]
Wang, JF [1 ]
Chen, YZ [1 ]
机构
[1] Natl Univ Singapore, Dept Computat Sci, Singapore 117543, Singapore
关键词
D O I
10.1093/bioinformatics/18.12.1699
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Drug absorption, distribution, metabolism and excretion (ADME) often involve interaction of a drug with specific proteins. Knowledge about these ADME-associated proteins is important in facilitating the study of the molecular mechanism of disposition and individual response as well as therapeutic action of drugs. It is also useful in the development and testing of pharmacokinetics prediction tools. Several databases describing specific classes of ADME-associated proteins have appeared. A new database, ADME-associated proteins (ADME-AP), is introduced to provide comprehensive information about all classes of ADME-associated proteins described in the literature including physiological function of each protein, pharmacokinetic effect, ADME classification, direction and driving force of disposition, location and tissue distribution, substrates, synonyms, gene name and protein availability in other species. Cross-links to other databases are also provided to facilitate the access of information about the sequence, 3D structure, function, polymorphisms, genetic disorders, nomenclature, ligand binding properties and related literatures of each protein. ADME-AP currently contains entries for 321 proteins and 964 substrates.
引用
收藏
页码:1699 / 1700
页数:2
相关论文
共 10 条
  • [1] AN INTRODUCTION TO DRUG DISPOSITION - THE BASIC PRINCIPLES OF ABSORPTION, DISTRIBUTION, METABOLISM, AND EXCRETION
    CALDWELL, J
    GARDNER, I
    SWALES, N
    [J]. TOXICOLOGIC PATHOLOGY, 1995, 23 (02) : 102 - 114
  • [2] Chen YZ, 2001, PROTEINS, V43, P217, DOI 10.1002/1097-0134(20010501)43:2<217::AID-PROT1032>3.0.CO
  • [3] 2-G
  • [4] Computational methods for the prediction of 'drug-likeness'
    Clark, DE
    Pickett, SD
    [J]. DRUG DISCOVERY TODAY, 2000, 5 (02) : 49 - 58
  • [5] ADME/PK as part of a rational approach to drug discovery
    Eddershaw, PJ
    Beresford, AP
    Bayliss, MK
    [J]. DRUG DISCOVERY TODAY, 2000, 5 (09) : 409 - 414
  • [6] GREEN MD, 1994, DRUG METAB DISPOS, V22, P799
  • [7] The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors
    Kim, RB
    Fromm, MF
    Wandel, C
    Leake, B
    Wood, AJJ
    Roden, DM
    Wilkinson, GR
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (02) : 289 - 294
  • [8] Development of predictive pharmacokinetic simulation models for drug discovery
    Norris, DA
    Leesman, GD
    Sinko, PJ
    Grass, GM
    [J]. JOURNAL OF CONTROLLED RELEASE, 2000, 65 (1-2) : 55 - 62
  • [9] ANALYSIS OF THE 5 GLYCOSYLATION SITES OF HUMAN ALPHA-1-ACID GLYCOPROTEIN
    TREUHEIT, MJ
    COSTELLO, CE
    HALSALL, HB
    [J]. BIOCHEMICAL JOURNAL, 1992, 283 : 105 - 112
  • [10] Role of organic cation transporters in drug absorption and elimination
    Zhang, L
    Brett, CM
    Giacomini, KM
    [J]. ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1998, 38 : 431 - 460